Verus Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $454K | Buy |
9,810
+3,389
| +53% | +$157K | 0.04% | 252 |
|
|
2025
Q1 | $392K | Buy |
6,421
+278
| +5% | +$17K | 0.04% | 268 |
|
|
2024
Q4 | $347K | Sell |
6,143
-188
| -3% | -$10.6K | 0.03% | 279 |
|
|
2024
Q3 | $328K | Sell |
6,331
-114
| -2% | -$5.9K | 0.03% | 274 |
|
|
2024
Q2 | $268K | Sell |
6,445
-1,147
| -15% | -$47.6K | 0.03% | 308 |
|
|
2024
Q1 | $412K | Buy |
7,592
+861
| +13% | +$46.7K | 0.05% | 218 |
|
|
2023
Q4 | $345K | Buy |
6,731
+553
| +9% | +$28.4K | 0.04% | 217 |
|
|
2023
Q3 | $359K | Sell |
6,178
-389
| -6% | -$22.6K | 0.05% | 203 |
|
|
2023
Q2 | $420K | Sell |
6,567
-320
| -5% | -$20.5K | 0.06% | 182 |
|
|
2023
Q1 | $477K | Sell |
6,887
-15
| -0.2% | -$1.04K | 0.07% | 158 |
|
|
2022
Q4 | $497K | Sell |
6,902
-36
| -0.5% | -$2.59K | 0.09% | 147 |
|
|
2022
Q3 | $493K | Sell |
6,938
-135
| -2% | -$9.59K | 0.09% | 147 |
|
|
2022
Q2 | $639K | Sell |
7,073
-1,346
| -16% | -$122K | 0.13% | 123 |
|
|
2022
Q1 | $645K | Buy |
+8,419
| New | +$645K | 0.1% | 142 |
|
|
2020
Q1 | $875K | Buy |
15,690
+1,046
| +7% | +$58.3K | 0.27% | 56 |
|
|
2019
Q4 | $940K | Buy |
+14,644
| New | +$940K | 0.31% | 58 |
|